导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -1.27% | 2557/4773 |
| 近一周 | -3.01% | 3550/5462 |
| 近一月 | -7.80% | 3986/5421 |
| 近一季 | -14.43% | 4153/5209 |
| 近半年 | -2.78% | 2016/4920 |
| 近一年 | 1.04% | 2421/4366 |
| 近两年 | 56.08% | 1306/2954 |
| 近三年 | 28.23% | 1123/2253 |
| 成立以来 | 515.38% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.75% 2457/4961 |
21.41% 1177/5312 |
- - |
- - |
| 2025 | 25.25% 1725/4813 |
-0.82% 2422/3635 |
-0.76% 3021/4076 |
29.85% 1203/4524 |
-2.00% 3058/4813 |
| 2024 | 12.31% 1254/3463 |
0.35% 993/2808 |
-3.36% 1354/3014 |
19.62% 824/3129 |
-3.19% 2288/3463 |
| 2023 | -15.91% 1665/2656 |
4.42% 958/2280 |
-6.42% 1637/2385 |
-7.51% 1585/2515 |
-6.95% 1991/2655 |
| 2022 | -24.73% 1249/2207 |
-18.37% 1325/1919 |
8.83% 325/2016 |
-16.46% 1458/2113 |
1.43% 1271/2208 |
| 2021 | -0.90% 767/1822 |
-5.09% 905/1255 |
10.37% 469/1330 |
-7.95% 1091/1466 |
2.77% 524/1822 |
| 2020 | 48.11% 189/1250 |
-5.57% 430/1028 |
21.62% 230/1067 |
10.10% 589/1164 |
17.13% 137/1184 |
| 2019 | 53.85% 78/1092 |
36.95% 79/754 |
-2.95% 368/804 |
4.21% 212/850 |
11.08% 80/918 |
| 2018 | -33.23% 547/834 |
- - |
- - |
- - |
-14.31% 576/691 |
| 2017 | 23.69% 132/714 |
- - |
- - |
- - |
- - |
| 2016 | -15.08% 350/605 |
- - |
- - |
- - |
- - |
| 2015 | 20.79% 114/575 |
- - |
- - |
- - |
- - |
| 2014 | 32.60% 155/237 |
- - |
- - |
- - |
- - |
| 2013 | -4.19% 84/186 |
- - |
- - |
- - |
- - |
| 2012 | 2.14% 102/140 |
- - |
- - |
- - |
- - |
| 2011 | -29.66% 88/102 |
- - |
- - |
- - |
- - |
| 2010 | -3.66% 14/58 |
- - |
- - |
- - |
- - |
| 2009 | 103.96% 2/27 |
- - |
- - |
- - |
- - |
| 2008 | -60.61% 11/26 |
- - |
- - |
- - |
- - |
| 2007 | 149.90% 5/22 |
- - |
- - |
- - |
- - |
| 2006 | 116.92% 11/14 |
- - |
- - |
- - |
- - |
| 2005 | -1.47% 5/11 |
- - |
- - |
- - |
- - |
| 2004 | -9.49% 3/4 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 融通深证100指数A VS. 长安沪深300非周期A(740101) |